Skip to content

Stem Cell Therapy for Avascular Necrosis (AVN) in Miami: What Patients Should Know

Stem Cell Therapy for Avascular Necrosis (AVN) in Miami: What Patients Should Know

Greice Murphy
Healthcare Executive & CEO, Miami Stem Cell®
5 min read

Table of Contents

Hip pain that gets worse with weight-bearing, groin pain that wakes you at night, a limp you cannot explain, and then an MRI that says “avascular necrosis.” For many people in Miami, that phrase is frightening. It sounds permanent, and many are told the only answer is a hip replacement.

The truth is more nuanced. Stem cell therapy for avascular necrosis is one of the more studied uses of regenerative medicine in orthopedics, especially when AVN is caught early. It is also an area where hype can run far ahead of the evidence. This guide explains what AVN is, what stem cell therapy can and cannot do, what research actually shows, who may be a candidate, and what to ask before you decide.

Short Answer: Can Stem Cell Therapy Help Avascular Necrosis?

It may help in early-stage AVN, but it is not a cure and it is not a replacement for proper medical care. The best-studied approach combines a surgical procedure called core decompression with bone marrow-derived cells (often bone marrow aspirate concentrate, or BMAC). A 2025 meta-analysis of 15 studies and 954 hips found that adding regenerative therapy to core decompression reduced the risk of femoral head collapse and of later hip replacement compared with core decompression alone, but the studies were varied, follow-up was short and the authors called the effect on slowing progression “uncertain.” Once the bone has collapsed or arthritis has set in, stem cells are unlikely to reverse the damage. These treatments are not FDA-approved for AVN.

Stem Cell Therapy for AVN at a Glance

  • What AVN is: Death of bone tissue because its blood supply is reduced. Also called osteonecrosis.
  • Most common site: The hip (femoral head), but the knee, shoulder and ankle can be affected too.
  • Best candidates: Early stages, before the bone surface has collapsed.
  • Best-studied approach: Core decompression plus bone marrow-derived cells.
  • What research shows: Fewer collapses and fewer hip replacements in pooled data, but with high variability between studies.
  • Not likely to help: Advanced collapse and severe arthritis.
  • Regulatory status: Not FDA-approved for AVN; considered investigational or offered under specific rules.
  • Next step: Get proper imaging and staging first, then discuss all options, including surgery.

What Is Avascular Necrosis (AVN)?

Bone is living tissue. It needs a steady blood supply to stay strong and to repair everyday micro-damage. In avascular necrosis, that blood flow drops, part of the bone dies, and the dead area gradually weakens. In the hip, the rounded top of the thigh bone (the femoral head) is especially vulnerable because its blood supply is limited. Over time, the surface can crack, flatten and collapse, damaging the cartilage and leading to arthritis.

Authoritative patient resources such as the NIAMS overview of osteonecrosis and the AAOS OrthoInfo page on osteonecrosis of the hip describe the condition in more detail.

Common causes and risk factors

  • Long-term or high-dose corticosteroid use (for lupus, asthma, autoimmune disease, or after some infections)
  • Heavy alcohol use
  • Injury, such as hip fracture or dislocation
  • Medical conditions, including sickle cell disease, some clotting disorders, and certain cancer treatments
  • Radiation or chemotherapy
  • Unknown causes (called idiopathic AVN), which are more common than many people expect

If you have any of these risk factors and develop deep hip, groin or buttock pain, mention it to your doctor right away. Early diagnosis changes your options.

Symptoms: When to Get Checked

AVN often begins quietly. Common signs include:

  • Pain in the groin, thigh or buttock that worsens with walking or standing
  • Pain at night or at rest as the disease progresses
  • Stiffness and reduced hip motion, especially turning the leg inward
  • A limp
  • Clicking or catching sensations if the bone surface has begun to collapse

Because these symptoms overlap with arthritis, a labral tear and bursitis, an MRI is usually needed. Early AVN can be invisible on an X-ray, which is why people are sometimes told “your X-ray is normal” for months. See also our guides on hip pain, hip labral tears and hip bursitis to understand how other conditions can mimic AVN.

Why the Stage of AVN Matters Most

The single most important factor in deciding whether a regenerative approach makes sense is how far the disease has progressed. Doctors often use the ARCO (Association Research Circulation Osseous) staging system, revised in 2019 and described in this PubMed summary:

ARCO stage What imaging shows Is bone collapsed? Typical thinking about stem cells
I X-ray normal; MRI or bone scan positive No Most favorable window
II X-ray shows subtle bone changes; no fracture or flattening No Still favorable
IIIA Fracture beneath the cartilage; depression 2 mm or less Early collapse Less certain; case by case
IIIB Fracture with depression more than 2 mm Late collapse Unlikely to restore shape
IV Osteoarthritis, narrowed joint, destruction Yes Not a stem cell problem; surgery is usually discussed

Think of it like a cracked eggshell. If the shell is intact but weakened, you may be able to support and protect it. Once it caves in, the shape is gone and supporting treatments cannot rebuild it.

This is why a good clinic starts with imaging and an honest staging conversation, not a sales pitch.

How Stem Cells Are Used for AVN

There are two broad ideas behind regenerative treatment of AVN.

1. Support the damaged bone from the inside. The area of dead bone is surrounded by a zone where repair is trying to happen but is overwhelmed. Delivering a concentrated dose of bone marrow cells, which contain stem and progenitor cells and growth signals, may help the body build new blood vessels and new bone.

2. Relieve the pressure first. In a procedure called core decompression, a surgeon drills one or more small channels into the femoral head to reduce pressure inside the bone and stimulate a healing response. Cells can be placed into this channel.

That second point matters. Injecting cells into the hip joint space is not the same as placing them into the necrotic bone. The research described below mostly involves cells delivered into the bone itself, usually during core decompression, often guided by imaging. An injection into the joint may help with pain and inflammation in arthritis, but it does not address dead bone in the femoral head in the same way. Ask any clinic exactly where the cells go, who performs the procedure and under what guidance.

For background on cell sources, see our pages on how mesenchymal stem cells are harvested, bone marrow aspirate vs. umbilical cord stem cells and autologous stem cell therapy.

What the Research Actually Shows

You deserve numbers, not adjectives. Here are the best summaries we reviewed.

The 2025 meta-analysis (954 hips)

A systematic review and meta-analysis in Frontiers in Pharmacology (full text) pooled 15 studies (7 randomized trials and 8 cohort studies) with 954 hips in early AVN (ARCO I, II and IIIA). It compared core decompression plus regenerative therapy versus core decompression alone. The main findings:

Outcome Result for combined therapy vs. core decompression alone
Pain (visual analog scale) Lower pain, mean difference of about 13 points on a 100-point scale
Harris Hip Score Higher function, about 9 points better
Progression to femoral head collapse Risk ratio 0.55 (about 45% lower risk)
Conversion to total hip replacement Risk ratio 0.59 (about 41% lower risk)
Bone marrow aspirate concentrate (BMAC) only Strongest signal among the agents studied

The authors also noted that low-dose BMAC (under 20 mL) and patients younger than 40 seemed to do better.

Important limits the authors themselves listed:

  • Results varied a lot from study to study (high heterogeneity).
  • Follow-up was relatively short.
  • A funnel plot suggested publication bias, meaning positive studies may be more likely to be published.
  • Some included studies were low quality.
  • The authors described the effect on slowing progression as “uncertain” and called for longer, head-to-head trials.

An earlier meta-analysis

An earlier pooled analysis of 7 studies (Acta Orthopaedica) compared core decompression alone to core decompression plus autologous bone marrow cells. It found lower odds of structural collapse with cell therapy (odds ratio about 0.2), but the reduction in conversion to hip replacement did not reach statistical significance. The authors suggested the approach may be most useful in early, pre-collapse stages and described their conclusion as tentative.

Putting it together

Across studies, a consistent pattern shows up: early-stage AVN, treated with core decompression plus bone marrow cells, tends to do better than core decompression alone. That is encouraging. But “tends to” is not “will,” and the best studies still have weaknesses. No study shows that stem cells make dead bone fully regrow in everyone, and results in patients with advanced collapse are poor.

For a wider look at how cell studies are designed and judged, see our overview of mesenchymal stem cell clinical trials and our honest answer to does stem cell therapy work.

Who May Be a Candidate for Stem Cell Therapy for AVN?

A careful evaluation would typically look at:

  • Stage: Early, pre-collapse (ARCO I-II) is the most favorable. Early collapse (IIIA) may be considered case by case.
  • Size and location of the necrotic area: Smaller lesions that are not in the main weight-bearing zone generally have a better outlook.
  • Cause and ongoing risk: If steroid use or heavy alcohol use is ongoing, the underlying driver needs to be addressed.
  • Age and overall health: Younger patients appeared to do better in pooled data.
  • Symptoms and goals: Do you want to delay a hip replacement, reduce pain, or both?
  • Other conditions: Active infection, certain cancers, pregnancy and bleeding disorders may rule treatment out.

Who is less likely to benefit

  • People with advanced collapse or end-stage arthritis (ARCO IIIB-IV)
  • People whose AVN is caused by a driver that continues unchecked
  • Anyone hoping to avoid all follow-up imaging and medical supervision

If you are in that group, a hip replacement is often a safe, effective option. Read our balanced guide to stem cell therapy vs. hip replacement and the overview of whether stem cells are effective for hip or shoulder arthritis.

What Stem Cell Therapy Cannot Do for AVN

Honest clinics say this out loud:

  • It cannot rebuild a flattened, collapsed femoral head.
  • It cannot reverse established arthritis.
  • It does not replace weight-bearing guidance or follow-up imaging.
  • It cannot undo the cause (for example, ongoing high-dose steroids).
  • It does not come with a guarantee. Some patients still progress and need surgery.

If anyone promises that stem cells will “regrow your hip,” treat that as a red flag.

Treatment Options for AVN: Where Stem Cells Fit

Stem cell therapy is one of several tools. A full conversation should cover all of them.

Option Typical role
Observation and activity changes Very early or small lesions; protect the joint and monitor
Protected weight-bearing (crutches) Short-term pain relief; limited proof it changes the course
Medications for pain and inflammation Symptom control
Core decompression (alone) Early stage; reduces pressure
Core decompression plus bone marrow cells Early stage; best-studied regenerative approach
Bone grafting or osteotomy Selected younger patients; surgeon-dependent
Hip replacement Advanced collapse or arthritis; reliable pain relief and function

Nothing here is mutually exclusive. For example, trying a joint-preserving procedure first does not stop you from having a hip replacement later if needed. Learn more about non-surgical paths in our guides to non-surgical osteoarthritis treatment and joint regeneration.

The Procedure: What to Expect

Exact steps vary by physician and protocol, so confirm each with your own provider. A typical bone marrow-based approach looks like this:

  1. Evaluation and imaging. MRI (and sometimes CT) confirms the stage and size of the lesion. Your doctor reviews your history, medications, alcohol use and risk factors.
  2. Bone marrow collection. Using local anesthesia, a small amount of marrow is drawn, usually from the back of the pelvis. This takes about 15 to 30 minutes.
  3. Processing. The marrow is concentrated in a centrifuge to create BMAC. This takes roughly 15 to 20 minutes.
  4. Delivery. In studies, the concentrate is placed into the femoral head, typically through a core decompression channel and guided by imaging. This step usually requires a surgeon and a sterile setting.
  5. Recovery. Most protocols limit weight-bearing for a period, often with crutches, then gradually return to activity with physical therapy.

For a general walk-through, see how stem cell therapy is done and the recovery timeline.

Where Miami patients should be careful

Because delivery into the femoral head is a more involved step than a standard joint injection, ask directly:

  • Who performs the procedure, and are they an orthopedic surgeon?
  • Will the cells be placed into the bone, or only injected around the joint?
  • What imaging guidance is used?
  • If core decompression is needed, will it be done here or referred out, and how is care coordinated?

A clinic that is clear about its role (and honest about referring you when surgery is the better answer) is one you can trust more.

Recovery and Timeline

Recovery depends on the procedure used. For a bone marrow draw with a joint-area injection, many people resume light activity within days. For core decompression with cell placement, expect a longer protected period, and your surgeon will give specific limits.

In general:

  • First weeks: Pain from the procedure itself, with possible crutch use.
  • 1 to 3 months: Gradual return to normal walking and daily tasks with physical therapy.
  • 3 to 6 months: Follow-up imaging and assessment of pain and function.
  • 6 to 12 months and beyond: Longer-term imaging to check whether the bone is stable or progressing.

Improvement, if it comes, is usually gradual. See how soon you may notice improvement and how long results can last for joint regeneration.

Risks and Side Effects

Regenerative treatments are generally considered low risk compared with major surgery, but “low risk” is not “no risk.” Possible issues include:

  • Pain, bruising or soreness at the bone marrow collection site
  • Infection (rare, but serious)
  • Bleeding
  • Temporary increase in hip pain or swelling
  • Risks tied to anesthesia and to core decompression itself, such as fracture of the bone
  • No improvement, or continued progression of the disease

Because AVN may continue to progress regardless of treatment, regular follow-up imaging is part of safe care, not an optional extra. Read more in our guides on safety in joint regeneration, downsides to consider and possible side effects.

Is Stem Cell Therapy for AVN FDA-Approved?

No. No stem cell product is FDA-approved for treating avascular necrosis. The FDA regulates many cell-based products as biologics and has issued a consumer warning about unapproved stem cell therapies. Procedures that use your own bone marrow may fall under different rules depending on how the cells are processed and used, and state law adds another layer. Our explainers on FDA-approved stem cell treatments and the state’s orthopedic MSC approval break down what those rules mean for patients.

Practical takeaway: Ask the clinic which product is used, where it comes from, how it is processed, and what regulatory pathway it follows. A state rule allowing a type of use is not the same thing as FDA approval or proof that it works.

BMAC, PRP, Umbilical Cord Products and Exosomes: What Is the Difference for AVN?

Option What it is Evidence for AVN
BMAC Concentrated cells from your own bone marrow Strongest signal in pooled studies, mostly with core decompression
PRP Concentrated platelets from your blood Less supported for AVN as a stand-alone treatment; see our PRP therapy guide
Umbilical cord products Donor-derived tissue or cells Little direct AVN research; see BMC vs. umbilical cord stem cells
Exosomes Cell-derived vesicles, not living cells Very limited human evidence; see exosome FDA status

If your main goal is to address necrotic bone, the pooled data point most strongly to bone marrow-derived cells placed in the bone itself. Be cautious about products that promise the same results with a simple IV drip or a joint injection alone. Our page on IV vs. direct injection explains why delivery matters, and our comparison of PRP vs. stem cell therapy for joint pain may help you sort through options.

Cost of Stem Cell Therapy for AVN in Miami

Costs vary widely and are typically not covered by insurance when the treatment is considered investigational. Total cost depends on:

  • Whether core decompression is included (a surgical step with facility and anesthesia fees)
  • Imaging (MRI and follow-up scans)
  • The cell source and how it is processed
  • The number of treatments planned
  • Follow-up visits and physical therapy

Compare any quote carefully. Our pages on the average cost of stem cell therapy, stem cell therapy costs in Miami and the economics of stem cell therapy explain what drives pricing. If your insurance would cover a hip replacement but not a regenerative procedure, factor in the real tradeoffs, including time off work and the chance you might still need surgery later.

Questions to Ask Before You Book

Bring this list to any consultation.

  1. What stage is my AVN (ARCO or Ficat), and how large is the lesion?
  2. Am I likely a candidate, or would you advise another route?
  3. Where will the cells be placed, and who performs the procedure?
  4. What is the source and processing of the cells?
  5. What is the regulatory status of the product and the procedure?
  6. What does the research say for my stage, and what are its limits?
  7. What would success look like, and when will we judge it?
  8. What follow-up imaging do I need, and who coordinates it?
  9. What happens if I progress and need a hip replacement later?
  10. What is the total cost, and what is included?

Also read our guide on how to choose a stem cell therapy treatment center.

Living With AVN: Habits That Support Your Hip

Whatever treatment you choose, daily choices matter.

  • Follow weight-bearing guidance. Using crutches when advised can protect a weakened femoral head.
  • Address risk factors. Work with your doctor on steroid dosing and alcohol use.
  • Stay active in a joint-friendly way. Swimming, cycling and guided physical therapy keep muscles strong without pounding the hip.
  • Maintain a healthy weight. Less load means less stress on the joint.
  • Do not skip follow-ups. Imaging catches changes before they become painful.
  • Report new symptoms promptly. Sudden worsening pain or a new limp can signal collapse.

Our broader guides on stem cell therapy for joint pain in Miami and hip pain stem cell options in Miami offer additional context.

AVN Myths vs. Facts

Myth: “An AVN diagnosis means I need a hip replacement right away.” Fact: Many people with early disease have joint-preserving options, and the right choice depends on stage, lesion size and symptoms. Advanced collapse is where replacement becomes the most reliable path.

Myth: “A normal X-ray rules out AVN.” Fact: Early AVN can be invisible on X-ray. MRI is the more sensitive test, which is why persistent hip or groin pain deserves one.

Myth: “Stem cells can regrow a whole hip.” Fact: The research suggests stem cells may help early disease; it does not show they rebuild a collapsed femoral head.

Myth: “A simple IV infusion treats AVN.” Fact: The best-studied approach places cells in the affected bone. An IV or a joint-space injection is not the same thing.

Myth: “If I do stem cells, I can’t have surgery later.” Fact: Joint-preserving treatment does not close the door on a later hip replacement.

Myth: “No one gets AVN unless they drink or take steroids.” Fact: Many cases have no clear cause, and injury, medical conditions and other treatments can contribute.

Three Example Scenarios (Illustrative Only)

These are general examples to show how decisions can differ, not predictions or real patient stories.

Scenario 1: Early stage, younger adult. A 38-year-old has two months of groin pain. MRI shows a small lesion with no collapse (early stage). This is the profile where joint-preserving treatment, including core decompression with bone marrow cells, is most often discussed. The plan would include protected weight-bearing, addressing any risk factors, and scheduled follow-up imaging.

Scenario 2: Borderline early collapse. A 52-year-old has a larger lesion with a small area of depression at the bone surface. A specialist may discuss joint preservation but will be frank that the odds are less certain, and that hip replacement may remain the more predictable option. Shared decision-making matters most here.

Scenario 3: Advanced collapse with arthritis. A 64-year-old has a flattened femoral head and a narrowed joint space. Stem cells are unlikely to change the structure of the bone. A surgical consultation is the right next step, and a responsible clinic will say so, even if it means no treatment is sold.

What to Bring to Your Consultation

Being prepared makes a short visit far more useful. Bring:

  • Your MRI report and, if possible, the images on disc or a link. The report alone is helpful but images allow a second review.
  • X-rays and CT scans, if any, from the past year.
  • A medication list, including current and past steroid use with approximate doses and dates.
  • A summary of risk factors, such as alcohol use, prior injuries, blood disorders or cancer treatment.
  • Notes on your symptoms: when pain started, what makes it better or worse, and how far you can walk.
  • Prior treatments you have tried, such as physical therapy, injections or crutches.
  • Your goals: for example, “I want to avoid a replacement before my kids finish school,” or “I want to keep playing tennis.”

If you are coming to Miami from out of town, send records ahead of time so the consultation can focus on decisions rather than gathering information. Our guides to regenerative medicine for sports injuries and stem cell therapy for sports injuries may also be useful if AVN has interrupted an active lifestyle.

Red Flags When Researching Clinics

Cell therapy for AVN is a specialized area, and not every provider is equipped for it. Be cautious if you see any of the following:

  • A promise of a cure or guaranteed results. No honest clinician can offer that.
  • No imaging review before pricing. If a quote arrives before anyone has looked at your MRI, the plan is not individualized.
  • No mention of surgery or referral as an option. Good care includes saying “this is not for you” when appropriate.
  • Vague descriptions of the cell source. You should hear the source, how it is processed and why.
  • Pressure tactics. “Book today or lose the discount” is a sales line, not medicine.
  • Testimonials in place of data. Individual stories cannot show what works on average.
  • No plan for follow-up imaging. AVN requires monitoring over time.

You are entitled to take your records elsewhere, get a second opinion and compare. A clinic that welcomes that is usually one you can trust.

Frequently Asked Questions

Can stem cell therapy cure avascular necrosis?

No. Stem cell therapy has not been shown to cure AVN. In early stages it may reduce pain, slow progression and delay hip replacement for some patients, but results vary and are not guaranteed.

Does stem cell therapy work for AVN of the hip?

It may help in early, pre-collapse stages when bone marrow cells are combined with core decompression. A pooled analysis of 954 hips found lower collapse and hip replacement rates versus core decompression alone, though the studies varied and follow-up was short.

What stage of AVN is best for stem cell therapy?

Early stages, before the bone surface collapses (ARCO I-II), are the most favorable. Early collapse (IIIA) is case by case. Advanced collapse and arthritis are unlikely to respond.

Can stem cells regrow dead bone?

They may support repair in early disease, but there is no proof they regrow fully dead, collapsed bone. Do not rely on claims that they will rebuild your hip.

Is stem cell therapy for AVN FDA-approved?

No. No stem cell product is FDA-approved for AVN, and offerings fall under varying regulatory rules. Ask the clinic about the specific product and pathway.

What is core decompression with BMAC?

It is a procedure in which a surgeon drills a small channel into the femoral head to relieve pressure and then places concentrated bone marrow cells into the area. It is the best-studied regenerative approach for early AVN.

How much does stem cell therapy for AVN cost in Miami?

Costs vary based on whether surgery is included, imaging and follow-up, and insurance typically does not cover investigational treatment. Request a written, itemized quote.

How long does recovery take?

A simple marrow draw and injection may need only days of lighter activity, while core decompression usually involves weeks of protected weight-bearing and months of rehabilitation.

Can I still have a hip replacement after stem cell therapy?

Yes. Joint-preserving treatment does not prevent a future hip replacement if you need one.

Is AVN the same as arthritis?

No. AVN is loss of blood supply to bone; arthritis is wear or inflammation of the joint. AVN can lead to arthritis if the bone collapses.

Can AVN affect joints other than the hip?

Yes. It can affect the knee, shoulder, ankle and other bones, although the hip is the most common site and the one with the most research.

Should I try stem cells before surgery?

It depends on your stage, age, lesion size and goals. A frank discussion with an orthopedic specialist and a regenerative medicine physician is the best way to decide.

Bottom Line

Avascular necrosis is serious, but a diagnosis does not always mean an immediate hip replacement. For some people with early disease, stem cell therapy for avascular necrosis, especially bone marrow-derived cells placed into the bone alongside core decompression, may reduce pain and lower the chance of collapse. The evidence is promising but imperfect, and the treatment is not FDA-approved. Stage, lesion size, the underlying cause and who performs the procedure all matter.

If you are in Miami and want an honest, no-pressure opinion, book a free 15-minute consultation at Miami Stem Cell in South Miami, or contact our team with your MRI and questions. You can also learn more about us and see how we approach Miami hip care before you decide.

Disclaimer: Individual results vary. This is general information, not medical advice.

About the Author

Greice Murphy

Healthcare Executive & CEO at Miami Stem Cell®

Healthcare executive & founder of Miami Stem Cell®, transforming regenerative medicine and autism care with innovative stem cell treatments.

Table of Contents

Take the First Step Toward a Pain-Free Life

Don’t let pain hold you back. Contact us today to schedule your free consultation and start your journey to recovery!